Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- CheckyesterdayChange DetectedThe website’s footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedA sitewide NIH notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The website revision advances from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check29 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check50 days agoChange DetectedThe study record history now includes a new revision entry v3.7.0 and removes the previous revision v3.6.6, reflecting an update to the record's version history.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.6.6 replaces Revision: v3.6.5 in the page footer, indicating the current site revision level.SummaryDifference0.0%

- Check85 days agoChange DetectedA new revision entry v3.6.5 is added to the history and the previous v3.6.4 entry is removed, reflecting a small update to the record's revision history.SummaryDifference0.0%

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.